Skip to main content

Advertisement

SpringerLink
Log in

Usefulness of a Liver Biopsy in the Evaluation of Patients with Elevated ALT Values and Serological Markers of Hepatitis Viral Infection

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Our study objective was to determine the current use of liver biopsy in chronic viral hepatitis and how patient management is affected by the procedure. Members of the Italian Association of Hospital Gastroenterologists were asked to complete a questionnaire for patients submitted to biopsy. Their clinical diagnosis was compared with the histological diagnosis. Of 660 patients evaluated, we selected 535 cases with viral infection. Concordance of clinical vs histologic diagnosis amounted to 84.3%, with 92.7% sensitivity and 32.4% specificity rates for diagnosing chronic hepatitis; the clinical diagnosis was correct in only 24 of 57 cases with cirrhosis. In 20 cases (3.7%) additional diagnoses were provided. The biopsy was rated avoidable in 36.8% of cases. Knowledge about grading and staging was considered of value in 59.6 and 66.4% of cases, respectively; however, when it became available, the scheduled treatment with interferon was not changed in 81.7 and 80.9% of cases. In the majority of patients with abnormal ALT and infection with HCV and/or HBV, histology documents mild/moderate inflammation with minimal fibrosis and liver biopsy neither increases the accuracy of clinical diagnosis nor affects the choice of therapy. The data from this study support the view that liver biopsies are less helpful than conventionally understood.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Thomas C, Jacyna M, Waters J, Main J: Virus-host interactions in chronic hepatitis B virus infection. Semin Liver Dis 8:342–349, 1988

    Google Scholar 

  2. Lee WM: Hepatitis B virus infection. N Engl J Med 337:1733–1744, 1997

    Google Scholar 

  3. Abrignani S: Immune responses throughout hepatitis C virus (HCV) infection: HCV from the immune system point of view. Springer Semin Immunopathol 19:47–55, 1997

    Google Scholar 

  4. Gowans EJ, Bonino F: Hepatitis delta virus pathogenicity. In Hepatitis Delta Virus: Molecular Biology, Pathogenesis, and Clinical Aspects, SJ Hadziyannis, JM Taylor, F Bonino (eds). New York, Wiley-Liss, 1993, pp 125–130

    Google Scholar 

  5. Fattovich G, Rugge M, Brollo L, et al: Clinical virological and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B. Hepatology 6:167–172, 1986

    Google Scholar 

  6. Reichard O, Glaussmann H, Fryden A, et al: Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment. Hepatology 21:918–922, 1995

    Google Scholar 

  7. Marcellin P, Boyer N, Gervais A, et al: Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-a therapy. Ann Intern Med 127:875–881, 1997

    Google Scholar 

  8. Farci P, Mandas A, Coiana A, et al: Treatment of chronic hepatitis D with interferon alfa-2b. N Engl J Med 330:88–94, 1994

    Google Scholar 

  9. Caturelli E, Giacobbe A, Facciorusso D, et al: Percutaneous biopsy in diffuse liver disease: Increasing diagnostic yield and decreasing complication rate by routine ultrasound assessment of puncture site. Am J Gastroenterol b91:1318–1321, 1996

    Google Scholar 

  10. Ishak KG, Baptista A, Bianchi L, et al.: Histological grading and staging of chronic hepatitis. J Hepatol 22:696–699, 1995

    Google Scholar 

  11. Hultcrantz R, Glaussman H, Lindberg G, Nilsson LH: Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum transaminases. Scand J Gastroenterol 21:109–113, 1986

    Google Scholar 

  12. Friedman LS, Dienstag SL, Watkins E, et al.: Evaluation of blood donors with elevated serum alanine amino-transferase levels. Ann Intern Med 107:137–144, 1987

    Google Scholar 

  13. Van Ness MM, Dielh AM: Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes? Ann Intern Med 111:473–478, 1989

    Google Scholar 

  14. Hultcrantz R, Gabrielsson N: Patients with persistent elevation of aminotransferases: investigation with ultrasonography, radionuclide imaging and liver biopsy. J Intern Med 233:7–12, 1993

    Google Scholar 

  15. Celle G, Savarino V, Picciotto A, Magnolia MR, Scalabrini P, Dodero M: Is hepatic ultrasonography a valid alternative tool to liver biopsy? Report on 507 cases studied with both techniques. Dig Dis Sci 33:467–471, 1998

    Google Scholar 

  16. Van Leeuwen DJ, Wilson L, Crowe DR: Liver biopsy in the mid-1990s: questions and answers. Semin Liv Dis 15:340–359, 1995

    Google Scholar 

  17. Romagnuolo J, Jewell L, Jhangri G, Brain VG: Predicting the liver histology in chronic hepatitis C: how good is the clinician? Gastroenterology 116:383A, 1999

    Google Scholar 

  18. Cammell G, Younossi Z, Carey W: The utility of liver biopsy (LBx) in diagnosis of hepatitis C (HCV). Gastroenterology 112:A1236, 1997

    Google Scholar 

  19. Seeff LB: Natural history of viral hepatitis, type C. Gastrointest Dis 6:20–27, 1995

    Google Scholar 

  20. Guadagnino V, Stroffolini T, Rapicella M, et al.: Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: A community-based survey in Souythern Italy. Hepatology 26:1006–1011, 1997

    Google Scholar 

  21. J Perrillo RP: The role of liver biopsy in hepatitis C. Hepatology 26(Suppl 1):57S–61S, 1997

    Google Scholar 

  22. Alberti A, Morsica G, Chemello L, et al.: Hepatitis C viremia and liver disease in symptom-free individuals with anti-HCV. Lancet 340:697–698, 1992

    Google Scholar 

  23. Puoti C, Magrini A, Stati T, et al.: Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels. Hepatology 26:1393–1398, 1997

    Google Scholar 

  24. De Franchis R, Meucci G, Vecchi M, et al.: The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Intern Med 118:191–194, 1993

    Google Scholar 

  25. Dao T, Lecointe I, Galateau F, et al.: Apporte de la biopsie hépatique et de la sérologie du virus de l'hépatite C au diagnostic d'une augmentation modérée et prolongée des aminotrasferases. Gastroenterol Clin Biol 17:37–43, 1993

    Google Scholar 

  26. Committee for Antiviral Therapy of the Italian Association for the Study of the Liver: Guidelines for the treatment of chronic viral hepatitis. Ital J Gastroenterol Hepatol 29:597–600, 1997

    Google Scholar 

  27. National Institute of Health: Consensus development conference panel statement: Management of hepatitis C. Hepatology 26(Suppl 1):2S–10S, 1997

    Google Scholar 

  28. Hépatite C: Dépistage et traitement. Gastroenterol Clin Biol 20:S202–S211, 1997

    Google Scholar 

  29. Everhart JE, Stolar M, Hoofnagle JH: Management of hepatitis C: A national survey of gastroenterologists and hepatologists. Hepatology 26(Suppl 1):78S–82S, 1997

    Google Scholar 

  30. Schalm SW: The diagnosis of cirrhosis: clinical relevance and methodology. J Hepatol 27:1118–1119, 1997

    Google Scholar 

  31. Soloway RD, Baggenstoss AH, Schoenfield J, Summerskill WHJ: Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy. Dig Dis 16:1082–1086, 1971

    Google Scholar 

  32. Maharaj B, Maharaj RJ, Leary WP, et al.: Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1:523–525, 1986

    Google Scholar 

  33. Gaiani S, Gramantieri L, Venturoli N, et al.: What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy. J Hepatol 27:979–985, 1997

    Google Scholar 

  34. Pagliaro L, Rinaldi F, Craxi A, et al.: Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis. A prospective randomized trial. Dig Dis Sci 28:39–43, 1983

    Google Scholar 

  35. Esposito C, Garipoli V, De Pasquale M, Porreca A, Raia V, Vajro P: Percutaneous blind needle biopsy versus combined excisional and guided needle biopsy in the diagnosis of liver disorders in pediatric patients. Ital J Gastroenterol Hepatol 29:179–181, 1997

    Google Scholar 

  36. Bennett WG, Inoue Y, Beck JR, Wong JB, Pauker SG, Davis GL: Estimates of the cost-effectiveness of a 6 month course of interferon-a 2b in patients with histologically mild active hepatitis C. Ann Intern Med 127:855–865, 1997

    Google Scholar 

  37. Marcellin P, Pouteau M, Benhamou JP: Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction. J Hepatol 22:364–369, 1995

    Google Scholar 

  38. Davis JL: Recombinant alpha-interferon treatment of non A, and non B (type C) hepatitis: Review of studies and recommendations for treatment. J Hepatol 11(Suppl 1):S72–S77, 1990

    Google Scholar 

  39. Battezzati PM, Podda M, Bruno S: Factors predicting early response to treatment with recombinant interferon-alpha 2a in chronic non-A, non B hepatitis. Ital J Gastroenterol Hepatol 24:481–484, 1992

    Google Scholar 

  40. Pagliaro L, Craxi A, Cammaa C, et al.: Interferon-alpha for chronic hepatitis C: An analysis of pre-treatment clinical predictors of response. Hepatology 19:820–828, 1994

    Google Scholar 

  41. Martinot-Perignoux M, Boyer N, Pouteau M, et al.: Predictors of sustained response to alpha interferon therapy in chronic hepatitis C. J Hepatol 29:214–223, 1998

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, “Casa Sollievo della Sofferenza” Hospital, IRCCS, San Giovanni Rotondo

    Angelo Andriulli & Virginia Festa

  2. Division of Gastroenterology, “De Bellis” Hospital, IRCCS, Castellana Grotte

    Gioacchino Leandro

  3. Department of Gastroenterology, San Giovanni Battista–Molinette Hospital, Turin

    Mario Rizzetto

  4. Associazione Italiana dei Gastroenterologi Ospedalieri, Italy

    Mario Rizzetto

Authors
  1. Angelo Andriulli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Virginia Festa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gioacchino Leandro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mario Rizzetto
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Andriulli, A., Festa, V., Leandro, G. et al. Usefulness of a Liver Biopsy in the Evaluation of Patients with Elevated ALT Values and Serological Markers of Hepatitis Viral Infection. Dig Dis Sci 46, 1409–1415 (2001). https://doi.org/10.1023/A:1010675401415

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1010675401415

Search

Navigation